These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 28455240

  • 21. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R, Mok MT, Kang W, Lau SS, Yip WK, Chen Y, Lai PB, Wong VW, To KF, Sung JJ, Cheng AS, Chan HL.
    J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ.
    World J Gastroenterol; 2016 Jun 14; 22(22):5183-92. PubMed ID: 27298561
    [Abstract] [Full Text] [Related]

  • 24. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH, Sze KMF, Lau EYT, Chiu YT, Lee JMF, Ng IOL, Lee TKW.
    Oncotarget; 2017 Apr 04; 8(14):23507-23516. PubMed ID: 28186991
    [Abstract] [Full Text] [Related]

  • 25. Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma.
    Wang C, Wang MD, Cheng P, Huang H, Dong W, Zhang WW, Li PP, Lin C, Pan ZY, Wu MC, Zhou WP.
    Cell Death Dis; 2017 Jan 19; 8(1):e2560. PubMed ID: 28102846
    [Abstract] [Full Text] [Related]

  • 26. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW, Yang FC, Lu HQ, Zhang JS.
    World J Gastroenterol; 2016 Feb 14; 22(6):1943-52. PubMed ID: 26877602
    [Abstract] [Full Text] [Related]

  • 27. Hepatitis B Virus-Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape.
    Meng Y, Shu Z, Wang X, Hong L, Wang B, Jiang J, He K, Cao Q, Shi F, Wang H, Gong L, Diao H.
    Mol Cancer Res; 2024 Jul 02; 22(7):642-655. PubMed ID: 38546386
    [Abstract] [Full Text] [Related]

  • 28. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
    Ng KY, Chai S, Tong M, Guan XY, Lin CH, Ching YP, Xie D, Cheng AS, Ma S.
    Oncotarget; 2016 Apr 26; 7(17):24005-17. PubMed ID: 27006468
    [Abstract] [Full Text] [Related]

  • 29. CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma.
    Liu K, Hao M, Ouyang Y, Zheng J, Chen D.
    Sci Rep; 2017 Jan 30; 7():41499. PubMed ID: 28134312
    [Abstract] [Full Text] [Related]

  • 30. Peroxiredoxin II Is Essential for Maintaining Stemness by Redox Regulation in Liver Cancer Cells.
    Kwon T, Bak Y, Park YH, Jang GB, Nam JS, Yoo JE, Park YN, Bak IS, Kim JM, Yoon DY, Yu DY.
    Stem Cells; 2016 May 30; 34(5):1188-97. PubMed ID: 26866938
    [Abstract] [Full Text] [Related]

  • 31. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
    Xiangji L, Feng X, Qingbao C, Weifeng T, Xiaoqing J, Baihe Z, Feng S, Hongyang W, Mengchao W.
    J Viral Hepat; 2011 Sep 30; 18(9):653-60. PubMed ID: 20642484
    [Abstract] [Full Text] [Related]

  • 32. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.
    Fan HX, Feng YJ, Zhao XP, He YZ, Tang H.
    Life Sci; 2018 Nov 15; 213():9-17. PubMed ID: 30308183
    [Abstract] [Full Text] [Related]

  • 33. TIMM29 interacts with hepatitis B virus preS1 to modulate the HBV life cycle.
    Muriungi NG, Ueda K.
    Microbiol Immunol; 2020 Dec 15; 64(12):792-809. PubMed ID: 32970362
    [Abstract] [Full Text] [Related]

  • 34. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X, Zhao XF, Liang XQ, Chen R, Pan YF, Liang J.
    Biomed Pharmacother; 2017 Jun 15; 90():100-108. PubMed ID: 28343069
    [Abstract] [Full Text] [Related]

  • 35. Incomplete radiofrequency ablation promotes the development of CD133+ cancer stem cells in hepatocellular carcinoma cell line HepG2 via inducing SOX9 expression.
    Yuan CW, Wang ZC, Liu K, Liu DJ.
    Hepatobiliary Pancreat Dis Int; 2018 Oct 15; 17(5):416-422. PubMed ID: 30262419
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP, Xiao ZL, Yang Z, Li J, Feng GX, Chen FQ, Li YH, Feng JY, Gao YE, Ye LH, Zhang XD.
    Acta Pharmacol Sin; 2015 Oct 15; 36(10):1228-36. PubMed ID: 26073327
    [Abstract] [Full Text] [Related]

  • 37. Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model.
    Anfuso B, El-Khobar KE, Ie SI, Avellini C, Radillo O, Raseni A, Tiribelli C, Sukowati CHC.
    Sci Rep; 2018 Sep 03; 8(1):13168. PubMed ID: 30177788
    [Abstract] [Full Text] [Related]

  • 38. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
    Chaturvedi VK, Singh A, Dubey SK, Hetta HF, John J, Singh MP.
    Microb Pathog; 2019 Mar 03; 128():184-194. PubMed ID: 30611768
    [Abstract] [Full Text] [Related]

  • 39. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K.
    J Hepatol; 2012 Sep 03; 57(3):600-12. PubMed ID: 22613004
    [Abstract] [Full Text] [Related]

  • 40. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z, Li G, Gou Y, Xiao D, Luo G, Saavedra JE, Liu J, Wang H.
    Biomed Pharmacother; 2017 Aug 03; 92():989-997. PubMed ID: 28605880
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.